HDAC10 and nonpapillary renal cell carcinoma: Upon comprehensive consideration, both the TCGA data and our clinical data from the Chinese PLA General Hospital cohort indicate that upregulation of HDAC10 lead to malignant progression of ccRCC, potentially serving as a useful prognostic marker for ccRCC.